American pharmacy retailer Walgreens confirmed to the market that it will start selling novelty cannabidiol (CBD) products, spokesman Brian Faith told CNBC on Wednesday (March 27).

Faith said the products align with the retailer’s efforts to offer “health and wellbeing products and services.”

Close to 1,500 stores across Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana will serve as the launch sites for sales of CBD creams, patches and sprays.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

The pharmacy is part of a larger holdings company, Walgreens Boots Alliance (NASDAQ:WBA). Walgreens did not disclose which specific brands it will start selling.

This move is seen as a response to competitor CVS Pharmacy (NYSE:CVS).

CVS told Bloomberg that it has commenced sales of creams, sprays and lotions in eight states. However, no supplements or food additives with CBD are being considered for sale.

As part of its 2018 year-end financial conference call, Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) announced on March 20 that its hemp-derived CBD brand will be sold in 800 CVS stores. The launch is confirmed for 10 states.

“I think that, in anticipation of the farm bill last year, many retailers were trying to come to a strategy for how they were going to address hemp,” Joseph Lusardi, CEO of Curaleaf, said during a call with investors and analysts.

The CBD ingredient has received a boost thanks to the legalization of hemp. Multiple products in the health and wellness market have adopted the cannabis-based component.

Neal Gilmer, cannabis analyst with Haywood Securities, previously told the Investing News Network that his bullish sentiment on the CBD market is due to the anecdotal information getting through to consumers.

Several multi-state operators in the public space have confirmed intentions of launching CBD-focused brands.

In addition, Canopy Growth (NYSE:CGC,TSX:WEED) announced an expansion in New York state for the production of similar hemp-derived products. The Canadian firm also secured a partnership with Martha Stewart for the launch of CBD brands.

The excitement for this market has even accelerated beyond health regulators. Questions remain on the regulation of products making false claims and other CBD-related novelty products sold online.

In a weekly email newsletter to investors, Alan Brochstein, cannabis analyst with 420 Investor, said uncertainty stemming from US Food and Drug Administration Commissioner Scott Gottlieb’s retirement and lack of clarity from federal powers have led to “the status of hemp and CBD at the state level [being] in disarray.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit:

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less